KAN0438757

CAS : 1451255-59-6

Ref. 3D-BIC25559

Informations sur le produit

• Nom: KAN0438757
• Marque: Biosynth
• Description: KAN0438757 is a research compound that is being developed as a potential treatment for cancer. It has been shown to have anti-proliferative effects in vitro, and it has also been shown to inhibit transcription and translation of genes. KAN0438757 inhibits the activity of transcriptional regulators that are involved in tumorigenesis and metastasis, such as NF-κB, STAT3, and PI3K. KAN0438757 was found to be metabolically stable, with significant effects on the long-term efficacy of the drug. This compound may have translational significance because it could potentially be used for the treatment of different types of cancer.

Propriétés chimiques

• Masse moléculaire: 447.4 g/mol
• Formule: C₂₁H₁₈FNO₇S
• Degré de pureté: Min. 95%